A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea
(Q47901914)
scientific article published on 14 February 2002
scientific article published on 14 February 2002
Language: